RPG Life SciencesNSE:RPGLIFE +2.62%92 Interest Coverage is 69.46 as of Mar. 2026, which is 33% below its 10-year median of 103.60. GuruFocus rates NSE:RPGLIFE with a GF Score™ of 92/100 and a GF Value™ of ₹2,363.48 (Fairly Valued). The stock has 3 warning signs investors should review. Among 686 Drug Manufacturers companies, RPG Life Sciences ranks better than 82.51% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. RPG Life Sciences's
Operating Income
for the
three
months ended in Mar. 2026 was ₹271 Mil. RPG Life Sciences's Interest Expense for the
three
months ended in Mar. 2026 was ₹-4 Mil.
RPG Life Sciences's interest coverage for the quarter that ended in Mar. 2026 was 69.46.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. RPG Life Sciences Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for RPG Life Sciences's Interest Coverage or its related term are showing as below:
NSE:RPGLIFE'
s Interest Coverage Range Over the Past 10 Years
Min: 4.81 Med: 103.6 Max: 286.71
Current: 141.13
NSE:RPGLIFE's Interest Coverage is ranked better than 82.51% of 686
companies
in the Drug Manufacturers industry
Industry Median: 12.725
vs NSE:RPGLIFE: 141.13
RPG Life Sciences (NSE:RPGLIFE) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
RPG Life Sciences Interest Coverage Related Terms
RPG Life Sciences Interest Coverage Historical Data
* Premium members only.
The historical data trend for RPG Life Sciences's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
NSE:RPGLIFE vs ZTS, UTHR: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, RPG Life Sciences's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RPG Life Sciences Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, RPG Life Sciences's Interest Coverage distribution charts can be found below:
* The bar in red indicates where RPG Life Sciences's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RPG Life Sciences (NSE:RPGLIFE) has a Interest Coverage of 69.46 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on RPG Life Sciences and its competitors. This is 33% below median its historical median of 103.60. Over the past decade, RPG Life Sciences' Interest Coverage has ranged from 4.81 to 286.71. According to the industry distribution chart, RPG Life Sciences ranks #120 out of 686 companies in the Drug Manufacturers industry, placing it in the top 17.5%.
Is RPG Life Sciences' Interest Coverage too high?
RPG Life Sciences' current Interest Coverage of 69.46 is 33% below median its 10-year median of 103.60. Over the past 10 years, this metric has ranged from a low of 4.81 to a high of 286.71. The Drug Manufacturers industry median Interest Coverage is 12.73. RPG Life Sciences' value of 69.46 is 445.9% above this industry median. Based on the distribution chart, RPG Life Sciences ranks #120 out of 686 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, RPG Life Sciences has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does RPG Life Sciences' Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, RPG Life Sciences ranks #120 out of 686 companies for Interest Coverage. This places RPG Life Sciences in the top 18% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 12.73. RPG Life Sciences' value of 69.46 is 445.9% above this benchmark. Historically, RPG Life Sciences' own Interest Coverage has ranged from 4.81 to 286.71 over the past decade. While the company's 10-year median is 103.60 vs. the industry median of 12.73, RPG Life Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.73, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. RPG Life Sciences's current Interest Coverage of 69.46 is 445.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on RPG Life Sciences and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RPG Life Sciences's current Interest Coverage is 69.46, which is 33% below median its own 10-year median of 103.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RPG Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, RPG Life Sciences (NSE:RPGLIFE) is currently considered Fairly Valued. The stock's GF Value™ is ₹2,363.48, compared to a current price of ₹2,352.60 — trading 0.5% below its estimated fair value. The current Interest Coverage is 69.46, which is 33% below median its 10-year median of 103.60 and 445.9% above the Drug Manufacturers industry median of 12.73. RPG Life Sciences' overall GF Score™ is 92/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For RPG Life Sciences (NSE:RPGLIFE), the current Interest Coverage is 69.46 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RPG Life Sciences (NSE:RPGLIFE) Overvalued in 2026?
Based on GuruFocus' analysis, RPG Life Sciences stock appears to be undervalued.
The current stock price of ₹2,352.60 is trading 0.5% below its estimated GF Value™ of ₹2,363.48.
GuruFocus considers RPG Life Sciences to be Fairly Valued.
Key valuation signals for NSE:RPGLIFE:
Interest Coverage: 69.46 (33% below median its 10-year median of 103.60)
GF Value™: ₹2,363.48 vs. price of ₹2,352.60 (0.5% below fair value)
Industry Position: 445.9% above the Drug Manufacturers median (#120 of 686)
No single metric tells the full story. See the NSE:RPGLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RPG Life Sciences Ltd is an integrated pharmaceutical company. Its only reportable segment is the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India. The company operates across Domestic Formulations, International Formulations and Active Pharmaceutical Ingredients (API). It focuses on Nephrology, Oncology, Urology, Respiratory, Gastrointestinal, Cardiovascular, Gynaecology and Pediatrics, Vitamins and Minerals, Pain Management, Neurology, Anti-Dengue, Anti-Diabetic, and Derma.
92GF Score
Get the complete analysis for NSE:RPGLIFE
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:RPGLIFE has been successfully added to your 
